Cargando…
Evaluation of plasma levels of BDNF in patients with disorder depressive
INTRODUCTION: According to the World Health Organization (WHO, 2017) depressive disorder continues to be the most widespread and growing mental illness in the world, also assumes that in 2020 depression will have a prevalence equal to one in six individuals. Studies of neuroanatomy have highlighted...
Autores principales: | Galletta, D., Mazzarino, C., Cusumano, G., Santoro, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471097/ http://dx.doi.org/10.1192/j.eurpsy.2021.898 |
Ejemplares similares
-
Decreased Plasma BDNF Levels of Patients with Somatization Disorder
por: Kang, Nam-In, et al.
Publicado: (2016) -
Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients
por: Aldoghachi, Asraa Faris, et al.
Publicado: (2019) -
Effect of psychotherapy on peripheral BDNF concentration levels in patients with bipolar disorder. A systematic review
por: Valtueña García, M., et al.
Publicado: (2023) -
PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016) -
Preliminary study on changes in BDNF in patients with depression after percutaneous coronary intervention
por: Medved, S., et al.
Publicado: (2023)